Skip to Content

关于应对近期政策变化的重要更新,请点击此处查看详情。

Merck
CN

SML2769

Sigma-Aldrich

ASS234

≥98% (HPLC)

Synonym(s):

N,1-Dimethyl-5-[3-[1-(phenylmethyl)-4-piperidinyl]propoxy]-N-2-propyn-1-yl-1H-indole-2-methanamine, N-[[5-[3-(1-Benzylpiperidin-4-yl)propoxy]-1-methyl-1H-indol-2-yl]methyl]-N-methyl-2-propyn-1-amine

Sign Into View Organizational & Contract Pricing

Select a Size

1 EA
CN¥15,802.30

CN¥15,802.30


Please contact Customer Service for Availability

Request a Bulk Order

Select a Size

Change View
1 EA
CN¥15,802.30

About This Item

Empirical Formula (Hill Notation):
C29H37N3O
CAS Number:
Molecular Weight:
443.62
UNSPSC Code:
12352200
NACRES:
NA.77

CN¥15,802.30


Please contact Customer Service for Availability

Request a Bulk Order

Quality Level

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

CN1C(CN(CC#C)C)=CC2=C1C=CC(OCCCC(CC3)CCN3CC4=CC=CC=C4)=C2

InChI key

ADCBAOTWERXLAP-UHFFFAOYSA-N

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
GF38122893GF80164964GF15199331
铂 foil, not light tested, 100x100mm, thickness 0.01mm, as rolled, 99.95%

GF95421450

铂 foil, not light tested, 100x100mm, thickness 0.004mm, as rolled, 99.95%

GF38122893

铂 foil, not light tested, 100x100mm, thickness 0.005mm, as rolled, 99.95%

GF80164964

铂 foil, not light tested, 100x100mm, thickness 0.002mm, as rolled, 99.95%

GF15199331

manufacturer/tradename

Goodfellow 954-214-50

manufacturer/tradename

Goodfellow 381-228-93

manufacturer/tradename

Goodfellow 801-649-64

manufacturer/tradename

Goodfellow 151-993-31

form

foil

form

foil

form

foil

form

foil

bp

3827 °C (lit.)

bp

3827 °C (lit.)

bp

3827 °C (lit.)

bp

3827 °C (lit.)

resistivity

10.6 μΩ-cm, 20°C

resistivity

10.6 μΩ-cm, 20°C

resistivity

10.6 μΩ-cm, 20°C

resistivity

10.6 μΩ-cm, 20°C

mp

1772 °C (lit.)

mp

1772 °C (lit.)

mp

1772 °C (lit.)

mp

1772 °C (lit.)

Biochem/physiol Actions

ASS234 is a brain-penetrant and orally active multi-target small molecule (MTSM) against (acetyl & butyryl) cholinesterases (hAChE/hBuChE IC50 = 0.81/1.82 μM), monoamine oxidases (hMAO-A/B IC50 = 0.27/120 nM), histamine H3 receptor (hH3R Ki = 84.2 nM; hH4R Ki >10 μM) and sigma-1/2 receptors (hS1R/rS2R = 2.82/50.3 nM). ASS234 exhibits antioxidative and neuroprotective effects in SH-SY5Y cultures (5 μM) and demonstrates therapeutic efficacy in neurodegerative disease models in vivo via sc. (0.62 mg/kg/d mice; 5 mg/kg rats), ip. (1 mg/kg mice) or po. (1 & 10 mg/kg mice).
Orally active, brain-penetrant, multi-target ligand against MAO-A/B, cholinesterases, H3 & sigma receptors with neuroprotective and pro-cognitive efficacy in vivo.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Regulatory Information

新产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Óscar M Bautista-Aguilera et al.
Angewandte Chemie (International ed. in English), 56(41), 12765-12769 (2017-09-02)
The therapy of complex neurodegenerative diseases requires the development of multitarget-directed drugs (MTDs). Novel indole derivatives with inhibitory activity towards acetyl/butyrylcholinesterases and monoamine oxidases A/B as well as the histamine H3 receptor (H3R) were obtained by optimization of the neuroprotectant
Javier Del Pino et al.
ACS chemical neuroscience, 9(12), 2880-2885 (2018-07-27)
There is clear evidence that neuroinflammation plays a crucial role in the pathogenesis of Alzheimer's disease. Consequently, modulating the inflammatory environment in brain has become a powerful and attractive strategy to deal with Alzheimer's disease physiopathology. In spite of the
José Marco-Contelles et al.
Frontiers in neuroscience, 10, 294-294 (2016-07-23)
ASS2324 is a hybrid compound resulting from the juxtaposition of donepezil and the propargylamine PF9601N ASS2324 is a multi-target directed propargylamine able to bind to all the AChE/BuChE and MAO A/B enzymesASS2324 shows antioxidant, neuroprotective and suitable permeability propertiesASS2324 restores
Anna Stasiak et al.
Current pharmaceutical design, 20(2), 161-171 (2013-05-25)
Neurodegenerative disorders are associated with different neurochemical and morphological alterations in the brain leading to cognitive and behavioural impairments. New therapeutic strategies comprise multifunctional drugs. The aim of the presented studies is to evaluate in vivo the novel compounds -
Wnt signaling pathway, a potential target for Alzheimer's disease treatment, is activated by a novel multitarget compound ASS234.
Javier del Pino et al.
CNS neuroscience & therapeutics, 20(6), 568-570 (2014-04-10)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service